Review highlights faster diagnostics for avian respiratory viruses

Version 2

A new review in Veterinary Sciences pulls together the expanding toolkit for diagnosing the poultry sector’s major respiratory viral threats, focusing on avian influenza virus, Newcastle disease virus, infectious bronchitis virus, and infectious laryngotracheitis virus. Its central message is straightforward: as these pathogens continue to overlap clinically, co-circulate, and evolve, diagnostic strategy is becoming just as important as diagnostic sensitivity. The review highlights a field moving from slower, single-target, laboratory-bound approaches toward multiplex, portable, and increasingly automated platforms. (citedrive.com)

That shift reflects a long-running problem in poultry medicine. Respiratory disease syndromes rarely present as neat, single-agent cases, and several major pathogens can produce similar signs. WOAH notes that Newcastle disease can closely resemble avian influenza clinically, making laboratory testing critical for confirmation, especially when highly pathogenic disease is a reportable event. Infectious bronchitis adds another layer of complexity because it is globally distributed, transmitted efficiently, and can present with respiratory, reproductive, or renal consequences depending on strain and flock context. (woah.org)

Against that backdrop, the review surveys both established and emerging options. According to the paper, qPCR remains a core technology, especially in multiplex formats, but the authors also point to growing interest in isothermal amplification methods, including LAMP, recombinase-aided amplification, and recombinase polymerase amplification, which may be more practical outside highly equipped laboratories. They also highlight CRISPR-Cas-based nucleic acid detection, high-throughput sequencing, microarrays, advanced immunoassays using nanomaterials or recombinant proteins, and integrated platforms such as microfluidic and smartphone-assisted systems. The article evaluates these methods in terms of sensitivity, turnaround time, multiplexing potential, and suitability for point-of-care use. (citedrive.com)

The broader literature supports that direction, while also tempering expectations. A recent Veterinary Research review on poultry respiratory syndromes described sensitive, specific, and time-efficient diagnostics as essential because mixed infections and subclinical disease can obscure the clinical picture. That review also noted that traditional viral methods can take 7 to 14 days, whereas molecular assays such as real-time PCR offer faster, more sensitive detection and are increasingly treated as the practical standard in many settings. It also pointed to multiplex and high-throughput formats that can screen multiple pathogens across large sample sets, which is increasingly relevant for commercial poultry systems. (link.springer.com)

Field experience shows why faster does not always mean simpler. The Animal Health Laboratory at the University of Guelph recently reported that avian metapneumovirus cases have continued in Ontario through 2025 and into 2026, and noted a familiar diagnostic challenge: the virus may only be present in upper respiratory tissues for roughly 6 to 7 days after infection. The lab advised early sampling from multiple acutely affected birds and, when appropriate, combining PCR with serology to improve case identification. Although aMPV is not one of the four viruses covered in the new review, the example illustrates a wider industry lesson: assay performance depends heavily on timing, specimen choice, and the clinical question being asked. (uoguelph.ca)

Why it matters: For veterinarians, diagnosticians, and poultry health teams, this review is less about a single breakthrough than about a maturing diagnostic framework. Faster molecular tools can improve triage, surveillance, and outbreak response, particularly where reportable or zoonotic pathogens are in the differential. But the review also points toward a more layered approach, where multiplex panels, confirmatory testing, sequencing, and field-deployable platforms each have a role. That is especially important as viral evolution can erode assay performance over time, and as health systems try to balance speed, cost, biosafety, and interpretive confidence. A separate 2026 MDPI review on avian influenza diagnostics similarly emphasized that ongoing viral evolution requires regular updates to PCR primers and probes, and that resource limitations still restrict access to advanced methods in some regions. (citedrive.com)

The policy context also matters. A Frontiers rapid review on avian influenza control in family poultry argues that surveillance and response do not operate in a vacuum, especially in smallholder settings. It found that early detection of both highly and low pathogenic avian influenza is often hindered by persistently high background mortality from enzootic diseases such as Newcastle disease and infectious bursal disease, which can mask unusual events and delay reporting. The review also emphasized that trust can be a limiting factor, particularly where producers have experienced uncompensated culling in past outbreaks. Its broader recommendation is a systems-oriented One Health approach: control efforts should be embedded in strategies that also improve poultry productivity, address structural constraints such as market access, feed systems, and control of endemic vaccine-preventable diseases, and use participatory, locally grounded approaches that recognize the lived experience of both women and men poultry keepers. Functional collaboration across animal health, public health, environmental sectors, and local government was presented as essential for reducing zoonotic risk while protecting livelihoods and food security.

In practical terms, that means the value of new assay platforms will depend not only on analytical performance, but on whether they fit real-world workflows in production systems, veterinary networks, and regional laboratories. Better diagnostics can strengthen control programs, but they work best when paired with reporting pathways, biosecurity, culturally appropriate preparedness and response protocols, and equitable access. For clinicians and poultry health programs, the message is that technical advances and system design have to move together.

What to watch: The next phase will likely center on validation and deployment: which multiplex and portable assays hold up across field conditions, how quickly genotype-aware tests can keep pace with viral change, and whether point-of-care tools can be integrated into surveillance and reporting without sacrificing accuracy. The bigger question is whether those tools can be embedded in One Health programs that are transparent, participatory, and workable for both commercial and family poultry systems.